Drug Shortage Report for CEFAZOLIN FOR INJECTION, USP

Last updated on 2020-07-08 History
Report ID 105945
Drug Identification Number 02237138
Brand name CEFAZOLIN FOR INJECTION, USP
Common or Proper name Cefazolin for Injection
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CEFAZOLIN
Strength(s) 1.0G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 1 G
ATC code J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-09-27
Estimated end date Unknown
Actual end date 2020-05-08
Shortage status Resolved
Updated date 2020-07-08
Company comments Remove from allocation
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-07-08 French Compare
v4 2020-07-08 English Compare
v3 2020-02-13 French Compare
v2 2020-02-13 French Compare
v1 2020-02-13 English Compare

Showing 1 to 5 of 5